Sartorius Opens New Plant in India

Article

In a ribbon-cutting ceremony held on October 30, 2009, Sartorius (Goettingen, Germany) inaugurated its new plant at the Sartorius Group's location in Bangalore, India.

In a ribbon-cutting ceremony held on October 30, 2009, Sartorius (Goettingen, Germany) inaugurated its new plant at the Sartorius Group's location in Bangalore, India. The new facility is designed to supply the Indian marketplace and additional Asian markets.

CEO Joachim Kreuzburg, Arnold Picot, supervisory board chairman, and Amit Chatterjee, managing director of Sartorius India, officially started up operations at the large building complex. At its new site, Sartorius has combined its five decentralized individual locations in Bangalore into a single new plant on premises, thus creating new capacity for the company's Indian business in both Group divisions.

The company's expanded capacity in India enables it to create and develop new process technologies and to custom-tailor these to meet customers' individual process requirements, according to the company press release.

Among other products, Sartorius in Bangalore, India, develops and manufactures bioreactors and additional equipment for pharmaceutical customers, laboratory equipment, as well scales and other weighing equipment for industrial applications.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Mike Schaefers Simtra BioPharma Solutions, Shiva Khalafpour MilliporeSigma, the Life Science Business of Merck KGaA, Darmstadt, Germany
Chris Hagan, SCIEX
Daniel Fischer, Tevard
Junevity Co-founder & CEO, John Hoekman, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.